vimarsana.com
Home
Live Updates
Roche receives FDA approval for VENTANA MMR RxDx Panel to id
Roche receives FDA approval for VENTANA MMR RxDx Panel to id
Roche receives FDA approval for VENTANA MMR RxDx Panel to identify dMMR solid tumour patients and pMMR endometrial cancer patients eligible for KEYTRUDA
/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of a label expansion for the VENTANA MMR RxDx...
Related Keywords
Germany ,
Japan ,
United States ,
Canada ,
Switzerland ,
America ,
German ,
Jo Lynn Garing ,
European Commission Approves ,
Genentech ,
Drug Administration ,
Merck Co Inc ,
Rxdx Panel ,
Roche Diagnostics Communications ,
Merck Sharp Dohme ,
Roche Group ,
Jill German ,
Optiview Amplification Kit ,
Dow Jones Sustainability Indices ,
Chugai Pharmaceutical ,
Merck Sharp ,
Natl Cancer ,
Opin Obstet ,
First Line Treatment ,
Mismatch Repair Deficient ,
Colorectal Cancer ,
Lynn Garing ,
Roche Diagnostics ,
Roche ,